E0167

· Eisai Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E0167, covering 2008-12-09 to 2008-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma [Phase 2, Phase 3]

See pricing